Background. Recurrence of hepatitis C virus (HCV) amount each individual immunosuppressant drug contribafter liver transplantation is almost universal and deutes to the acceleration of the natural history of HCV is creases both graft and patient survival . Medications controversial (4) . Answering these questions is difficult given that alter nucleic acid metabolism, including some the lack of cell-culture models for HCV . This requires a study common immunosuppressants used in HCV-infected of HCV in the context of closely related viruses or with HCV patients, may affect viral replication .
replicons, which consist of RNA elements coding for non-
Methods . Bovine viral diarrhea virus (BVDV) is in
structural proteins of HCV that can autonomously replicate the Flaviviridae family and is closely related to HCV .
in Huh7 hepatoma cells (5) . We measured the effect of two immunosuppressants, azathioprine (AZA) and mycophenolate acid (MPA), on Ribavirin has been shown to enhance the activity of interboth BVDV replication by plaque assay and host-cell feron in the treatment of HCV and increase the percentage of replication by flow cytometry. We also compared the sustained responders (6) . The exact mechanism of this eneffect of ribavirin and AZA on the level of HCV replihancement is unknown, although at high concentrations, con RNA by real-time reverse-transcriptase polymerribavirin can be incorporated into RNA viral genomes and ase chain reaction.
decrease replication (7) . Antimetabolite immunosuppres-
Results. At doses that achieved similar cytotoxicity, sants have some commonalties with ribavirin . Both ribavirin AZA decreased BVDV replication 10 times more than and mycophenolate acid (MPA) inhibit inosine monophos-MPA. The inhibition of BVDV by AZA occurred at lower doses than the cellular cytotoxicity and did not phate dehydrogenase (IMPDH) (8, 9) . This and other data depend on cytotoxicity. A two-log reduction in viral have led some to quantify the antiviral effect of MPA and titers occurred despite blocking the cytotoxicity of other IMPDH inhibitors (9) . At the same time, ribavirin and AZA by inhibiting ribonucleotide reductase with high three metabolites of azathioprine (AZA) are all processed to concentrations of thymidine . A metabolite of AZA, monophosphate nucleotides by IMPDH intracellularly (8, 6-mercaptopurine, still possessed this antiviral effect, 10), which then compete with endogenous nucleotide pools . but a metabolite further downstream, 6-thioguanine, Clinical data investigating potential antiviral effects of eidid not, even though 6-thioguanine is the metabolite ther AZA or MPA and whether different immunosuppressive responsible for cellular toxicity . The effect of AZA on a regimens are associated with different rates of HCV recur-HCV replicon was at least as large as that of ribavirin . rence are conflicting (11) (12) (13) (14) (15) Sigma (St . Louis, MO) . 6-mercaptopurine and ribavirin were pural. (17) . Samples were analyzed with the ABI 7700 Sequencer (Lanchased from ICN (Costa Mesa, CA) .
genfeld, Germany) and the OOCt calculated according to Stuyver et al. (18) . Plaque Assays Unless otherwise noted, freshly seeded MDBK cell monolayers (1x10 5 cells in a 100 mm dish) were seeded in the presence of RESULTS varying concentrations of antimetabolite drugs and incubated for 3
Comparison of Azathioprine and Mycophenolate on Bovine hours at 37°C, 5% C02 . Then, a low multiplicity inoculum (approxiViral Diarrhea Virus mately 0 .01 pfu/cell of were further incubated cp BVDV) was added, and cells with virus for 72 hours, after which the supernatant To begin to look for selective pressure that altered nuclewas collected . Mock-infected plates with the same drug exposure for otide pools may place on RNA viruses, we measured BVDV the same amount of time were trypsinized and counted in triplicate growth in MDBK cells exposed to MPA or AZA . When cells with a flow cytometer . Serial dilutions of each supernatant were were actively replicating (subconfluent cells), both MPA, and added to 4-hour old, newly seeded monolayers without any drug . One to a much lesser extent AZA, had cytostatic and toxic effects hour after infection, the inoculum was removed, and MDBK cell medium containing 1% methylcellulose was added to the monolayin addition to any potential specific antiviral effects (data not ers . Plaques were counted 96 hours postinfection . Dilutions that shown) . The cytostatic and toxic effects of MPA, presumably gave approximately 25 to 75 plaques per plate were repeated in attributable to decreased de novo purine synthesis from IMtriplicate .
PDH inhibition, were such that even very low concentrations of MPA killed all the cells when Real-Time RT-PCR ing . By allowing cells to reach the cells were rapidly dividconfluency and a slower to drug and virus, the effect HCV 1bN replicon with no adaptive mutations transfected into growth rate before exposing cells Huh7 cells (clone 1) (5) was kindly supplied by Stanley Lemon, of the drug on viral replication on an intact cell monolayer University of Texas, Galveston . Subconfluent cells were incubated could be evaluated (Fig. 1 ) . Under these conditions, the anfor 72 hours in the presence of media containing 1 mM thymidine tiviral effect of AZA was larger than that of MPA, with only alone or thymidine with either 100 µM ribavirin or 100 µM AZA . Effect of Azathioprine on Bovine Viral Diarrhea Virus does an appreciable not Depend on Cytotoxic Effects AZA itself.
The cytostatic and toxic effects of AZA are more modest decrease in than MPA and thus allowed the addition of AZA to rapidly effect . dividing cells, which in turn allowed more robust viral production . With increasing concentrations of AZA, viral produc-HCV Replicon tion was significantly curtailed, even at concentrations where no detectable decrease in cell growth occurred (Fig . 2) . Cell confluency The decrease in cell growth caused by AZA at higher concen- (18, 20) , trations can be prevented by high concentrations of thymi-thymidine dine (1 mM) . Under these conditions, DNA synthesis is lim-we also tested ited, so there should be no production and incorporation of Huh7 cells the toxic metabolite of AZA, 6-thioguanosine triphosphate, ence of 1 into cellular DNA (10) (Fig . 3) and therefore no cytotoxicity. rin . After The viral suppression (Fig . 2) still occurred, even though, amounts under these conditions, AZA caused no change in host cell the viral 5' growth . Because only a small minority of hepatocytes in a gene to normalize diseased liver (and even smaller minority in a normal liver) a one-cycle are actively dividing (19) , this cellular state of high thymi-the critical dine causing low cell turnover may mimic liver tissue better corresponds than rapidly dividing cells in a tissue culture dish .
cells exposed effect on cell growth, similar to the prodrug However, 6-mercaptopurine still caused a two-log BVDV replication, whereas 6-thioguanine had no is More Sensitive to Azathioprine than Ribavirin at Equivalent Doses affects the amount of HCV replicon per cell and, because high concentrations of AZA without does affect Huh7 cell confluency (data not shown), the HCV replicon in the presence of thymidine . bearing the 1bN replicon were grown in the presmM thymidine with no other drug, AZA, or ribavi-72 hours, total RNA was isolated, and equivalent were assayed by real-time RT-PCR with probes to untranslated region and a cellular housekeeping the results . AZA reliably produced almost increase in the number of cycles required to reach threshold (C t ) compared with no drug, which to only approximately 50% as much replicon in to AZA (Fig. 5 ) . Although this change was small with the effect of AZA on BVDV, it was of similar or larger than the change on the HCV replicon equimolar amounts of ribavirin . To begin to determine the mechanism of the antiviral effect of AZA, we examined whether any of the metabolites of AZA DISCUSSION ( Fig. 3) also had antiviral activity . 6-methyl mercaptopurine, AZA has been used in liver transplantation for more than 6-mercaptopurine, and 6-thioguanine were each individually 30 years . It is a prodrug that is converted to 6-mercaptopuadded to MDBK cells with or without BVDV . 6-methyl mer-rine and eventually into 6-thioinosine and 6-thioguanosine captopurine had no effect on cell growth or viral yield, triphosphate (Fig . 3) . The triphosphate of 6-thioguanosine is whereas both 6-mercaptopurine and 6-thioguanine decreased converted to deoxy6-thioguanosine and incorporated into celcell growth and viral yield (data not shown) . To isolate the lular DNA (21) . The thioribonucleotides are also available for antiviral effect, cells and virus were grown in the presence of inhibition or incorporation by viral enzymes including the thymidine with either 6-mercaptopurine or 6-thioguanine RNA polymerase . Therefore, AZA could share some proposed (Fig . 4) . In the presence of thymidine, neither metabolite had mechanisms with ribavirin that are dependent upon both 1000 ---w FIGURE 2 . AZA inhibition of RNA viral replication is more profound than the inhibition°o f cell growth. MDBK cells L 100
were grown in varying concen-°t rations of AZA with (dashed lines) and without ( (11, 12 ) . Yet, even in the face of more rejection, AZA has been associated with a variable amount of HCV recurrence . One MetIMP study showed less recurrence with an AZA-containing regi-, tIDP tGDP men versus a non-AZA-containing regimen (13), whereas another found more HCV recurrence in patients with higher MetlOP MetITP ttrP tGTP doses of AZA and corticosteroids (14) . Meanwhile, mycophenolate mofetil has also been associated with less HCV recurrence than AZA (11) , no benefit compared with a regimen tdGTP_ without mycophenolate mofetil or AZA (12), or an increased . DNA FIGURE 3. Thiopurine metabolism . AZA is a prodrug that is risk of graft failure (15) .
Given the molecular effect demonstrated in this report, metabolized to 6-mercaptopurine . 6-mercaptopurine is con-several issues need to be considered that might explain the verted to 6-methyl mercaptopurine (MeMP) or 6-mercaptopu-disparities in clinical trials . First, the degree of sensitivity to rive riboside (MPR) . In turn, MPR is converted to mono-, di-, AZA may depend on the specific strain of HCV . Second, and triphosphate derivatives of thioinosine (tIM(D,T)P), immunosuppressive regimens in transplantation are rapidly methyl thioinosine (MetIM(D,T)P), and thioguanosine (tGM-evolving multicomponent cocktails that are difficult to com-(D,T)P) . Any of these metabolites could be responsible for the pare between, and sometimes within, one study population . antiviral effect, and any triphosphate could potentially be Third, thiopurine metabolism differs between patients beincorporated into the viral genome . Only 6-thioguanosine is cause of polymorphisms in thiopurine methyltransferase and processed by ribonucleotide reductase into a deoxyribonu-possibly other loci, which may lead to variability in thiopucleotide (tdGTP) and incorporated into cellular DNA, and this step is blocked by 1 mM thymidine. Incorporation of ring levels after drug administration . Bergan et al . (27) above thiopurine nucleotides into cellular RNA has not been showed significant variability in 6-mercaptopurine plasma observed (10) . Metabolites of AZA decrease purine synthesis levels after oral AZA dosing in renal-transplant patients, through effects on glutamine-5-phosphoribosylpyrophos-with plasma concentrations up to approximately 1 µM . Alphate amidotransferase, whereas both mycophenolate acid though this represents the lower range of 6-mercaptopurine-(MPA) and ribavirin decrease GTP synthesis by inhibiting used in our study, previous data indicates that thiopurine inosine monophosphate dehydrogenase .
efficacy correlates more with intracellular nucleotide concendrugs being triphosphorylated and recognized by the viral trations as opposed to plasma levels (28) . Furthermore, studies in mice suggest that hepatic tissue levels of thiopurine metabolites are approximately fourfold greater than plasma replication machinery . levels (29) . The effect of ribavirin and many other antivirals as mono-
In conclusion, we present evidence that the antiviral effect therapy is quite small and, at least in the case of HIV, the of AZA is mediated by a thioinosine metabolite, perhaps by effect of nucleoside analogs is quickly obscured by the selec-being incorporated into the viral genome, as has been sugtion of viral resistance . In certain situations, the selection of gested to occur with ribavirin . If it is incorporated, the antiless-fit HIV viruses with mutant polymerases can be cliniviral effect could be mediated either through the induction of cally preferable to wild-type virulent HIV (22) . A similar mutations (5) or by altering RNA structure (18) , which, in detailed understanding regarding the selection of mutant turn, may affect enzyme processivity, ribosome translation, HCV viruses is lacking even though the HCV polymerase is or other properties of an RNA genome . Whether this will the likely target of ribavirin and possibly an indirect target of prove to be clinically useful depends in part upon how large other antimetabolite drugs, including IMPDH inhibitors .
the antiviral effect is relative to its immunosuppressive effect and obviously requires validation in more clinical trials . Case AZA causes the overall effect to be proviral, the antiviral reports exist of patients with both autoimmune hepatitis and effect may still select for specific viral mutants that are hepatitis C treated with AZA . However, the effect of AZA on synergistic (or antagonistic) to other antivirals . With this in HCV viral load in this setting is uncertain and is potentially mind, AZA's role in liver transplantation should be reevaluconfounded by the concomitant use of corticosteroids (30) . ated to determine whether it affects viral load or selects for Theoretically, even if the immunosuppressive property of AZA-resistant HCV . In a broader sense, the studies described here indicate an important line of future inquiry into the effects of HCV and other viruses on allograft integrity . They show that with appropriate models, it should be possible to 7 .2 parse the conflicting actions of immunosuppressants on virologic behavior through their direct actions, without the confounding effects of altered adaptive immunity . 
